Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab

被引：38
作者：
Bruns, I
Fox, F
Reinecke, P
Kobbe, G
Kronenwett, R
Jung, G
Haas, R
机构：
[1] Univ Klinikum Dusseldorf, Klin Hamatol Onkol & Klin Immunol, Dusseldorf, Germany
[2] Univ Klinikum Dusseldorf, Inst Pathol, Dusseldorf, Germany
[3] Univ Klinikum Dusseldorf, Inst Diagnost Radiol, Dusseldorf, Germany
来源：
LEUKEMIA | 2005年 / 19卷 / 11期
关键词：
D O I：
10.1038/sj.leu.2403936
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1993 / 1995
页数：3
相关论文
共 8 条
  • [1] Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10
    Attygalle, A
    Al-Jehani, R
    Diss, TC
    Munson, P
    Liu, HX
    Du, MQ
    Isaacson, PG
    Dogan, A
    [J]. BLOOD, 2002, 99 (02) : 627 - 633
  • [2] Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide
    Dogan, A
    Ngu, LSP
    Ng, SH
    Cervi, PL
    [J]. LEUKEMIA, 2005, 19 (05) : 873 - 875
  • [3] Combination of antiangiogenic therapy with other anticancer therapies: Results, challenges, and open questions
    Gasparini, G
    Longo, R
    Fanelli, M
    Teicher, BA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1295 - 1311
  • [4] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    Hurwitz, H
    Fehrenbacher, L
    Novotny, W
    Cartwright, T
    Hainsworth, J
    Heim, W
    Berlin, J
    Baron, A
    Griffing, S
    Holmgren, E
    Ferrara, N
    Fyfe, G
    Rogers, B
    Ross, R
    Kabbinavar, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2335 - 2342
  • [5] Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature
    Pautier, P
    Devidas, A
    Delmer, A
    Dombret, H
    Sutton, L
    Zini, JM
    Nedelec, G
    Molina, T
    Marolleau, JP
    Brice, P
    [J]. LEUKEMIA & LYMPHOMA, 1999, 32 (5-6) : 545 - 552
  • [6] Mechanisms and future directions for angiogenesis-based cancer therapies
    Scappaticci, FA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3906 - 3927
  • [7] Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo
    Wang, ES
    Teruya-Feldstein, J
    Wu, Y
    Zhu, ZP
    Hicklin, DJ
    Moore, MAS
    [J]. BLOOD, 2004, 104 (09) : 2893 - 2902
  • [8] Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression
    Zhao, WL
    Mourah, S
    Mounier, N
    Leboeuf, C
    Daneshpouy, ME
    Legrès, L
    Meignin, V
    Oksenhendler, E
    Le Maignin, C
    Calvo, F
    Brière, J
    Gisselbrecht, C
    Janin, A
    [J]. LABORATORY INVESTIGATION, 2004, 84 (11) : 1512 - 1519
1